3M

Tegaderm Absorbent Clear Acrylic Dressing. In this newest addition to the Tegaderm line of wound dressings, transparency and absorption are combined to allow clinicians to monitor pressure ulcers, skin tears, and other minimal to moderately exudating wounds without changing the dressing. The adhesive dressing features a breathable transparent dressing film top layer and a perforated moist skin adhesive bottom layer that "sandwich" a proprietary hydrophilic, acrylic polymer. It conforms to the skin to provide long wear time without causing damage to intact skin, and it creates a barrier to outside contaminants.

[black up pointing small triangle] Information:http://www.3M.com/healthcare

Wyeth

Tygacil (tigecycline). The first of the new class of glycycycline antibiotics to be approved by the Food and Drug Administration, Tygacil has a broad spectrum of antimicrobial activity, including activity against methicillin-resistant Staphylococcus aureus (MRSA). Tygacil is indicated for the treatment of a variety of complicated intra-abdominal infections and complicated skin and skin structure infections in adults, both hospital- and community-acquired, including complicated appendicitis, infected burns, intra-abdominal abscesses, deep soft tissue infections, and infected ulcers. The drug is administered intravenously every 12 hours, and it does not require dosage adjustment in patients with impaired renal function.

[black up pointing small triangle] Information:http://www.wyeth.com

IYIA Technologies

The Wound Treatment System. Designed to focus oxygen and hydration directly to damaged cells of diabetic foot wounds to aid in regeneration, this topical hyperbaric oxygen treatment system has received 501k clearance for marketing by the Food and Drug Administration.

The patient inserts the affected foot into the system's cart-like device, which hydrates the wound with a fine penetrating fog that can carry antibacterial or antimicrobial agents of the clinician's choosing, alternating with an application of oxygen under slight pressure. Each in-office session lasts about 1 hour. Clinical trials conducted over the summer demonstrated healing of open wounds in 4 to 6 weeks in patients whose wounds had not responded to 6 to 12 months of conventional treatment.

[black up pointing small triangle] Information:http://www.iyiatechnologies.com